Early Oral & Topical Anti-inflammatory Therapies for IBD

References: 5-ASA

  1. Crohn’s Colitis Canada. Sulfasalazine and 5 Aminosalicylates 5-ASA. https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Sulfasalazine-and-5-Aminosalicylates-5-ASA. Accessed October 15, 2024.
  2. Crohn’s Colitis Canada. Steroids. https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Steroids. Accessed October 15, 2024.
  3. Sulfasalazine Product Monograph. December 2018. Available from: https://pdf.hres.ca/dpd_pm/00049093.PDF. Accessed October 15, 2024.
  4. PENTASA® Product Monograph. June 2024. Available from: https://pdf.hres.ca/dpd_pm/00075957.PDF. Accessed October 15, 2024.
  5. SALOFALK® Product Monograph. June 2023. Available from: https://pdf.hres.ca/dpd_pm/00071176.PDF. Accessed October 15, 2024.
  6. MEZAVANT® Product Monograph. September 2021. Available from: https://pdf.hres.ca/dpd_pm/00063237.PDF. Accessed October 15, 2024.
  7. MEZERA® (suppository) Product Monograph. March 2018. Available from: https://pdf.hres.ca/dpd_pm/00044385.PDF. Accessed October 15, 2024.
  8. MEZERA® (oral) Product Monograph. August 2024. Available from: https://pdf.hres.ca/dpd_pm/00076540.PDF. Accessed October 15, 2024.
  9. OCTASA® Product Monograph. October 2023. Available from: https://pdf.hres.ca/dpd_pm/00073064.PDF. Accessed October 15, 2024.
  10. Turner D et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory care – An evidence-based guideline from European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67(2); 257-291.
  11. Ananthakrishnan A et al. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review. Gastroenterology 2021;160(1):445-451.
  12. Sturm A, et al. European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly. J Crohns Colitis 2017;11(3):263-273.

References: Corticosteroids

  1. Crohn’s Colitis Canada. Sulfasalazine and 5 Aminosalicylates 5-ASA. https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Sulfasalazine-and-5-Aminosalicylates-5-ASA. Accessed October 15, 2024.
  2. Crohn’s Colitis Canada. Steroids. https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Steroids. Accessed October 15, 2024.
  3. ENTOCORT® Product Monograph. April 2018. Available from: https://pdf.hres.ca/dpd_pm/00044077.PDF. Accessed December 11, 2024.
  4. UCERIS™ Foam Product Monograph. April 2020. Available from: https://bauschhealth.ca/wp-content/uploads/2022/06/Uceris-PM-E-2020-04-15.pdf. Accessed December 11, 2024.
  5. ENTOCORT® Capsules Product Monograph. April 2018. Available from: https://pdf.hres.ca/dpd_pm/00044730.PDF. Accessed December 11, 2024.
  6. CORTIMENT® MMX® Product Monograph. July 2016. Available from: https://www.ferring.ca/media/1039/cortiment-pm-control-no-183534-en_17jun2016-pdf.pdf. Accessed December 11, 2024.
  7. TEVA-PREDNISONE Tablets Product Monograph. June 2015. Available from: https://pdf.hres.ca/dpd_pm/00040705.PDF. Accessed December 11, 2024.
  8. APO-PREDNISONE Product Monograph. May 2015. Available from: https://pdf.hres.ca/dpd_pm/00030893.PDF. Accessed December 11, 2024.
  9. Taro-Methylprednisolone Injection Product Monograph. May 2024. Available from: https://pdf.hres.ca/dpd_pm/00075482.PDF. Accessed December 11, 2024.
  10. Mack, D.R. et al. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease. Journal of the Canadian Association of Gastroenterology 2018;2:e35 – e63.
  11. Escher JC, et al. European Collaborative Research Group on Budesonide in Paediatric IBD. Budesonide versus prednisolone for the treatment of active Crohn’s disease in children: a randomized, double-blind, controlled, multicentre trial. Eur J Gastroenterol Hepatol. 2004;16(1):47-54.
  12. Turner D, et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory care – An evidence-based guideline from European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67(2); 257-291.
  13. Van Rheenen P, et al. The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis 2021;15(2):171-194.
  14. Ananthakrishnan A et al. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review. Gastroenterology 2021;160(1):445-451.
  15. Sturm A, et al. European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly. J Crohns Colitis2017;11(3):263-273.
This tool is intended for Canadian Healthcare Professionals. Copyright © 2025 CANIBD Canadian IBD Nurses.

Contact Us    Provider Resources     References

CANIBD and Crohn's and Colitis Canada do not accept any responsibility or liability for the accuracy, content, completeness, legality, or reliability of the information contained in this Service. The content is not intended to diagnose, treat, cure or prevent disease. Content was developed in 2024 and is provided for informational purposes only.